Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-016072
Filing Date
2022-08-09
Accepted
2022-08-09 16:17:11
Documents
67
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q freq-20220630.htm   iXBRL 10-Q 3058039
2 EX-31.1 freq-ex31_1.htm EX-31.1 18197
3 EX-31.2 freq-ex31_2.htm EX-31.2 18180
4 EX-32.1 freq-ex32_1.htm EX-32.1 11689
5 EX-32.2 freq-ex32_2.htm EX-32.2 11705
  Complete submission text file 0000950170-22-016072.txt   8427696

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT freq-20220630_cal.xml EX-101.CAL 37834
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT freq-20220630_pre.xml EX-101.PRE 305022
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT freq-20220630_lab.xml EX-101.LAB 420581
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT freq-20220630_def.xml EX-101.DEF 181497
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT freq-20220630.xsd EX-101.SCH 46392
61 EXTRACTED XBRL INSTANCE DOCUMENT freq-20220630_htm.xml XML 1228278
Mailing Address 75 HAYDEN AVENUE SUITE 300 LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE SUITE 300 LEXINGTON MA 02421 781-315-4600
Frequency Therapeutics, Inc. (Filer) CIK: 0001703647 (see all company filings)

EIN.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39062 | Film No.: 221148556
SIC: 2834 Pharmaceutical Preparations